Systematic review of the serology assays used in COVID-19 seroprevalence surveys

A systematic review carried out by the CITF-funded SeroTracker team, released in preprint, and not yet peer reviewed, reported that third-party or independent evaluations from manufacturers found that the manufacturers appear to overstate the sensitivity and specificity of their serological assays targeting SARS-CoV-2.